Aethlon Medical Inc.

1.81+0.0200+1.12%Vol 43.96K1Y Perf 13.92%
Apr 19th, 2021 14:14 DELAYED
BID1.79 ASK1.80
Open1.78 Previous Close1.79
Pre-Market- After-Market-
 - -%  - -
Target Price
7.00 
Analyst Rating
— 0.00
Potential %
288.89 
Finscreener Ranking
★★★★+     57.26
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★+     50.60
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★★+     67.40
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Market Cap21.96M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
24.71 
Earnings Date
10th Feb 2021

Today's Price Range

1.781.82

52W Range

1.183.73

5 Year PE Ratio Range

-4.70-2.70

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-13.11%
1 Month
-19.73%
3 Months
-29.53%
6 Months
7.19%
1 Year
13.92%
3 Years
-91.41%
5 Years
-97.83%
10 Years
-98.09%

TickerPriceChg.Chg.%
AEMD1.810.02001.12
AAPL134.600.44000.33
GOOG2 301.033.27000.14
MSFT258.81-1.9300-0.74
XOM56.08-0.5800-1.02
WFC44.250.41000.94
JNJ162.440.20000.12
FB301.68-4.5000-1.47
GE13.400.01000.07
JPM153.17-0.1300-0.08
Financial StrengthValueIndustryS&P 500US Markets
9.90
10.00
0.00
0.01
-4 843.50
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-
-891.10
-886.70
-2 068.80
-
RevenueValueIndustryS&P 500US Markets
624.87K
0.05
64.75
-4.27
Earnings HistoryEstimateReportedSurprise %
Q03 2021-0.15-0.20-33.33
Q02 2021-0.12-0.15-25.00
Q01 2021--0.15-
Q03 2020-1.03-0.2872.82
Q02 2020-1.10-1.29-17.27
Q01 2020-1.20-1.65-37.50
Q04 2019-1.20-1.35-12.50
Q03 2019-1.05-1.65-57.14
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.21-90.91Negative
3/2021 QR-0.110.00-
3/2021 FY-0.71-29.09Negative
3/2022 FY-1.20-179.07Negative
Next Report Date-
Estimated EPS Next Report-0.15
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume43.96K
Shares Outstanding12.13M
Trades Count186
Dollar Volume400.98K
Avg. Volume470.92K
Avg. Weekly Volume82.14K
Avg. Monthly Volume156.15K
Avg. Quarterly Volume455.42K

Aethlon Medical Inc. (NASDAQ: AEMD) stock closed at 1.79 per share at the end of the most recent trading day (a -4.28% change compared to the prior day closing price) with a volume of 125.79K shares and market capitalization of 21.96M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 8 people. Aethlon Medical Inc. CEO is Charles J. Fisher.

The one-year performance of Aethlon Medical Inc. stock is 13.92%, while year-to-date (YTD) performance is -27.53%. AEMD stock has a five-year performance of -97.83%. Its 52-week range is between 1.18 and 3.73, which gives AEMD stock a 52-week price range ratio of 24.71%

Aethlon Medical Inc. currently has a PE ratio of 14.40, a price-to-book (PB) ratio of 2.26, a price-to-sale (PS) ratio of 36.69, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -83.37%, a ROC of -94.12% and a ROE of -93.44%. The company’s profit margin is -%, its EBITDA margin is -886.70%, and its revenue ttm is $624.87 Thousand , which makes it $0.05 revenue per share.

Of the last four earnings reports from Aethlon Medical Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.15 for the next earnings report. Aethlon Medical Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Aethlon Medical Inc. is (0), with a target price of $7, which is +288.89% compared to the current price. The earnings rating for Aethlon Medical Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aethlon Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aethlon Medical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.40, ATR14 : 0.22, CCI20 : -180.30, Chaikin Money Flow : -0.20, MACD : -0.17, Money Flow Index : 37.84, ROC : -11.82, RSI : 37.20, STOCH (14,3) : 4.35, STOCH RSI : 0.18, UO : 42.71, Williams %R : -95.65), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aethlon Medical Inc. in the last 12-months were: Chetan S. Shah (Sold 26 852 shares of value $56 580 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Aethlon Medical Inc.

Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment.

CEO: Charles J. Fisher

Telephone: +1 858 459-7800

Address: 9635 Granite Ridge Drive, San Diego 92123, CA, US

Number of employees: 8

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

67%33%

Bearish Bullish

56%44%

Bearish Bullish

57%43%

News

Stocktwits